Acotec Scientific Holdings Ltd (HKG: 6669), a China-based medical device company, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its innovative peripheral scoring balloon dilation catheter, Peridge. This device is designed for the treatment of occlusive lesions in autologous or synthetic arteriovenous fistulas used for hemodialysis.
The Peridge catheter offers a significant advancement in vascular intervention by providing an effective fixation point that aids in the precise orientation of plaque openings. As it expands the lumen, the device minimizes the occurrence and severity of elastic recoil and flow-limiting dissection associated with plaque or proliferative endometrial tissue. Furthermore, it reduces excessive damage to blood vessels, thereby facilitating better vascular preparation for the subsequent treatment with drug-coated balloons (DCB).
This NMPA approval is a testament to Acotec’s commitment to innovation in the field of vascular devices and enhances the company’s portfolio, offering healthcare providers and patients a new option for the management of vascular access in hemodialysis.- Flcube.com
